Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening

• Egile Nagusiak: Diana G. Redwood (Egilea), Ian D. Blake (Egilea), Ellen M. Provost (Egilea), John B. Kisiel (Egilea), Frank D. Sacco (Egilea), David A. Ahlquist (Egilea)
• Formatua: Liburua
• Argitaratua: SAGE Publishing, 2019-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objective: Alaska Native (AN) people have among the world's highest rate of colorectal cancer (CRC). We assessed perceptions of AN people and their health care providers of a new take-home multitarget stool DNA test (MT-sDNA; Cologuard) relative to colonoscopy. Methods: Cross-sectional surveys...